Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-10-16

Clinical Trial Update: Increased Activity of a Renal Salt Transporter (ENaC) in Diabetic Kidney Disease [NA]

View source ↗

Summary

This trial update investigates increased activity of the renal ENaC transporter in diabetic nephropathy, with relevance to hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Southern Denmark | Conditions: Diabetic Nephropathies, Hypertension | NA | Status: UNKNOWN